United Kingdom blood glucose monitoring devices market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027. The market growth can be attributed to surge in the demand for the technologically advanced monitoring devices. Increasing cases of diabetes and growing geriatric population propel the growth of the United Kingdom blood glucose monitoring devices market in the upcoming five years. Higher prevalence of sedentary lifestyle, unhealthy eating habits, and laid back lifestyle of the younger population has shifted large sections of the population be contracting diabetes thereby growing the demand for the glucose monitoring devices and thus the growth of the United Kingdom blood glucose monitoring devices market in the future five years.
Blood glucose monitoring devices are self-defining medical devices that are used to monitor the irregular concentration of glucose in the blood. Diabetic patients require blood glucose monitoring devices to keep a regular check over their sugar intakes and changing blood sugar level. The patients suffering from type 1 diabetes produce less amount of insulin. Or the insulin being produced by the pancreas in the human body gets attacked by their own immune system thus the digestion of sugar molecule fails. Blood glucose monitoring devices monitor the level of sugar in the blood. The devices can be a self-monitoring device that includes a glucometer to analyze the blood sample, test strips to procure the sample on and to be inserted in the glucometer for the test, and lancets to prick the finger to collect blood sample. The device usually comes with an in-built screen or mobile based applications that displays the sugar level. There are continuous blood glucose monitoring devices too, that are usually worn on body. In certain cases, the sensors are placed under the skin of belly or on the back of arm. A transmitter is attached to the sensor sends information to the wireless monitor usually clipped over the belt.
Growing Disease Burden Drives Market Growth
Increasing instances of diabetes majorly type 2 diabetes is driving the growth of the United Kingdom blood glucose monitoring devices market in the upcoming five years. Increasing geriatric population of the country and genetic evolution leads to increasing instances of type 2 diabetes among the population. As per records, the government predicts with no changes in the lifestyle of the population, the country may account for over 5.5 million population be suffering from diabetes. Over 90% of the population suffers from type 2 diabetes and the female population is highly susceptible to type 2 diabetes about 44.3% and the male population suffers more from type1 diabetes about 56.5% as of 2021.
Furthermore, the patients suffering from diabetes are at high risk of heart failures, heart attacks, and other cardiovascular diseases. The immune system of the patient suffers too, the patient is often at higher risk of contracting infectious disease and severity in various cases might lead to death. Also, during the recent pandemic condition, diabetic patients were at the highest risk. Thus, increasing instances of diabetes is actively influencing the demands and thus the growth of the United Kingdom blood glucose monitoring devices market in the future five years.
Click here to download the sample
Market Segmentation
The United Kingdom blood glucose monitoring devices market is segmented by
Company Profile
Abbott Laboratories Limited, Johnson & Johnson Limited, Medtronic UK, Roche Diagnostics Limited, Becton Dickinson U.K. Limited, Nipro Medical UK Limited, Bayer UK Limited
| Attribute | Details |
| Base Year | 2021 |
| Historical Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, volume in units, and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · Product Type · Application · End User |
| Regional scope | London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside |
| Key companies profiled | Abbott Laboratories Limited, Johnson & Johnson Limited, Medtronic UK, Roche Diagnostics Limited, Becton Dickinson U.K. Limited, Nipro Medical UK Limited, Bayer UK Limited |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
